Important Webinar: AVI Clinical Trial Update

AVI Clinical Trial Update

Parent Project Muscular Dystrophy presents an AVI webinar on Wednesday, March 21 at 1pm eastern. The webinar will cover a pre-data update on AVI BioPharma's Phase IIb study evaluating eteplirsen for the treatment of Duchenne patients with mutations amenable to exon-51 skipping, and will be lead by Chris Garabedian, the CEO of AVI BioPharma.

  • Topic: AVI Clinical Trial Update
  • When: Wednesday, March 21 at 1pm eastern


To Participate

If you are unable to attend this webinar, a link will be provided and posted on our website afterwards that will allow you to download the entire presentation.


Read more PPMD Blogs

Views: 893


You need to be a member of PPMD Community to add comments!

Join PPMD Community

Need help using this community site? Visit Ning's Help Page.



© 2021   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service